SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-111022
Filing Date
2012-03-13
Accepted
2012-03-13 08:06:57
Documents
3
Period of Report
2012-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d313990d8k.htm 8-K 16511
2 PRESS RELEASE DATED MARCH 13, 2012 d313990dex991.htm EX-99.1 84860
3 GRAPHIC g313990g95b63.jpg GRAPHIC 14319
  Complete submission text file 0001193125-12-111022.txt   122357
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 12685826
SIC: 2834 Pharmaceutical Preparations